(*contributed equally to this work) 发布: 2019年08月20日第9卷第16期 DOI: 10.21769/BioProtoc.3343 浏览次数: 3645
评审: Gal HaimovichWilliam C. W. ChenAnonymous reviewer(s)
相关实验方案
一种基于qPCR 的高通量研究 SOD1G93A小鼠模型中相对拷贝数的基因分型方法
Valerie R. Tassinari and Fernando G. Vieira
2019年06月20日 6458 阅读
Abstract
Organic anion transporting polypeptide (OATP) 1B1 is a liver-specific transport protein that plays an important role in hepatic drug disposition. It transports many drugs from the blood into the liver, including lipid-lowering statins. The c. 521 T>C polymorphism of OATP1B1 has reduced transport activity and is associated with statin-induced myopathy. Formalin-fixed paraffin-embedded (FFPE) liver tissues can be an enriched source for genotyping of this clinically significant OATP1B1 polymorphism in retrospective studies. The successfulness of genotyping using Sanger-sequencing of a PCR product from FFPE tissue relies on a successful PCR amplification using genomic DNA extracted from the FFPE tissues. Such PCR amplification is often limited by the quality of DNA extracted from the FFPE tissue. An optimized method for high-quality DNA extraction and efficient PCR amplification is highly needed in order to genotype polymorphisms such as the c. 521 T>C polymorphism using FFPE tissues. The current study established an optimized and reproducible method for a Sanger-sequencing-based genotyping method using FFPE human liver tissues that is applicable to even small FFPE tissues such as needle-core biopsy specimens.
Keywords: Membrane transport proteins (膜转运蛋白)Background
Organic anion transporting polypeptide (OATP) 1B1 is a liver-specific transport protein that plays an important role in hepatic drug disposition (Shitara et al., 2013; Khurana et al., 2014; Lee et al., 2015). It transports many drugs from blood into the liver including lipid-lowering statins, anti-cancer and anti-hepatitis C virus drugs (Hsiang et al., 1999; Hirano et al., 2004; Simonson et al., 2004; Nozawa et al., 2005; Feng et al., 2009; Oostendorp et al., 2009; Hartkoorn et al., 2010). The c. 521 T>C polymorphism of OATP1B1 has reduced transport activity and is associated with altered toxicity of drugs that are OATP1B1 substrates such as statins. Genotyping the c. 521 T>C of OATP1B1 using archived liver FFPE tissue allows retrospective correlation of the transport activity of OATP1B1 due to genetic variation with toxicity and efficacy of drugs that are OATP1B1 substrates, indicating its significant clinical relevance. The Sanger-sequencing-based genotyping method using FFPE tissues is often limited by the lack of an efficient PCR product using DNA template extracted from the FFPE tissues. A recent publication reported that the DNA template from the FFPE tissue itself can inhibit the PCR efficiency (Dietrich et al., 2013). Based on this finding, we optimized the DNA template amount used for PCR and suggest an upper limit of DNA that should not be exceeded for PCR in FFPE tissue. We also identified an efficient kit for DNA purification for the FFPE tissue. We report an optimized, reproducible protocol for PCR using FFPE DNA as template.
Materials and Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2019 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Crowe, A., Miller, J. and Yue, W. (2019). Genotyping of the OATP1B1 c. 521 T>C Polymorphism from the Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Specimens: An Optimized Protocol. Bio-protocol 9(16): e3343. DOI: 10.21769/BioProtoc.3343.
分类
分子生物学 > DNA > 基因分型
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link